Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma. Cancer Australia has released data exploring the relationships between early and late stage diagnosis of cancer treatment. Melanoma, Australia’s national cancer was revealed to have a 92% early detection rate. Thanks to early detection, prevention and awareness, this is a great statistic for melanoma. To highlight the significance of this, the data discovered that only around 18% of lung cancer patients are diagnosed at an early stage.
Cancer Australia’s CEO Dr Helen Zorbas said “I think there is strong data that indicates the benefit of screening”. Comparatively, Australia is doing well in early stage diagnosis when positioned next to Canada and the UK. Dr Zorbas recognised that there has been a gap in the research on national data on the stage at diagnosis.
The data is a major leap forward in cancer control. A collaborative development led by Cancer Australia, the Australian Institute of Health and Welfare and state cancer registries all contributed to the data. Not only has the data examined early diagnosis, it will also help correlate between cancer stage at diagnosis and survival outcomes. Additionally, this data is likely to improve survival rates in all cancer patients. This data will benefit the dissemination of national cancer information and procurement of data in the future.
For more information about early diagnosis melanoma data go to: https://ncci.canceraustralia.gov.au/cancer-types/melanoma